{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:03:56Z","timestamp":1792242236397,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11640-y","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T14:24:34Z","timestamp":1750775074000},"page":"8217-8227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of diffusion-weighted and contrast-enhanced MRI for monitoring response to neoadjuvant therapy in breast cancer"],"prefix":"10.1007","volume":"35","author":[{"given":"Hye Joung","family":"Eom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9672-844X","authenticated-orcid":false,"given":"Hak Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hee","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"11640_CR1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M et al (2014) Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 384:164\u2013172. https:\/\/doi.org\/10.1016\/S0140-6736(13)62422-8","journal-title":"Lancet"},{"key":"11640_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s13244-013-0219-y","volume":"4","author":"MB Lobbes","year":"2013","unstructured":"Lobbes MB, Prevos R, Smidt M et al (2013) The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review. Insights Imaging 4:163\u2013175. https:\/\/doi.org\/10.1007\/s13244-013-0219-y","journal-title":"Insights Imaging"},{"key":"11640_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/jnci\/djs528","volume":"105","author":"ML Marinovich","year":"2013","unstructured":"Marinovich ML, Houssami N, Macaskill P et al (2013) Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy. J Natl Cancer Inst 105:321\u2013333. https:\/\/doi.org\/10.1093\/jnci\/djs528","journal-title":"J Natl Cancer Inst"},{"key":"11640_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1664-4","volume":"15","author":"ML Marinovich","year":"2015","unstructured":"Marinovich ML, Macaskill P, Irwig L et al (2015) Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis. BMC Cancer 15:662. https:\/\/doi.org\/10.1186\/s12885-015-1664-4","journal-title":"BMC Cancer"},{"key":"11640_CR5","doi-asserted-by":"publisher","first-page":"868","DOI":"10.2214\/ajr.184.3.01840868","volume":"184","author":"E Yeh","year":"2005","unstructured":"Yeh E, Slanetz P, Kopans DB et al (2005) Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184:868\u2013877. https:\/\/doi.org\/10.2214\/ajr.184.3.01840868","journal-title":"AJR Am J Roentgenol"},{"key":"11640_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10549-012-2033-5","volume":"135","author":"LM Wu","year":"2012","unstructured":"Wu LM, Hu JN, Gu HY, Hua J, Chen J, Xu JR (2012) Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?. Breast Cancer Res Treat 135:17\u201328. https:\/\/doi.org\/10.1007\/s10549-012-2033-5","journal-title":"Breast Cancer Res Treat"},{"key":"11640_CR7","doi-asserted-by":"publisher","first-page":"844790","DOI":"10.3389\/fonc.2022.844790","volume":"12","author":"AM Mendez","year":"2022","unstructured":"Mendez AM, Fang LK, Meriwether CH et al (2022) Diffusion breast MRI: current standard and emerging techniques. Front Oncol 12:844790. https:\/\/doi.org\/10.3389\/fonc.2022.844790","journal-title":"Front Oncol"},{"key":"11640_CR8","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.18632\/oncotarget.23195","volume":"9","author":"W Chu","year":"2018","unstructured":"Chu W, Jin W, Liu D et al (2018) Diffusion-weighted imaging in identifying breast cancer pathological response to neoadjuvant chemotherapy: a meta-analysis. Oncotarget 9:7088\u20137100. https:\/\/doi.org\/10.18632\/oncotarget.23195","journal-title":"Oncotarget"},{"key":"11640_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00330-011-2236-x","volume":"22","author":"SH Park","year":"2012","unstructured":"Park SH, Moon WK, Cho N et al (2012) Comparison of diffusion-weighted MR imaging and FDG PET\/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer. Eur Radiol 22:18\u201325. https:\/\/doi.org\/10.1007\/s00330-011-2236-x","journal-title":"Eur Radiol"},{"key":"11640_CR10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/j.1524-4741.2011.01160.x","volume":"17","author":"P Belli","year":"2011","unstructured":"Belli P, Costantini M, Ierardi C et al (2011) Diffusion-weighted imaging in evaluating the response to neoadjuvant breast cancer treatment. Breast J 17:610\u2013619. https:\/\/doi.org\/10.1111\/j.1524-4741.2011.01160.x","journal-title":"Breast J"},{"key":"11640_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1148\/radiol.2542090405","volume":"254","author":"R Woodhams","year":"2010","unstructured":"Woodhams R, Kakita S, Hata H et al (2010) Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging-comparison with contrast-enhanced MR imaging and pathologic findings. Radiology 254:357\u2013366. https:\/\/doi.org\/10.1148\/radiol.2542090405","journal-title":"Radiology"},{"key":"11640_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/nbm.1245","volume":"22","author":"U Sharma","year":"2009","unstructured":"Sharma U, Danishad KK, Seenu V, Jagannathan NR (2009) Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 22:104\u2013113. https:\/\/doi.org\/10.1002\/nbm.1245","journal-title":"NMR Biomed"},{"key":"11640_CR13","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1148\/radiol.2018180273","volume":"289","author":"SC Partridge","year":"2018","unstructured":"Partridge SC, Zhang Z, Newitt DC et al (2018) Diffusion-weighted MRI findings predict pathologic response in neoadjuvant treatment of breast cancer: the ACRIN 6698 multicenter trial. Radiology 289:618\u2013627. https:\/\/doi.org\/10.1148\/radiol.2018180273","journal-title":"Radiology"},{"key":"11640_CR14","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/nbm.2807","volume":"25","author":"HJ Shin","year":"2012","unstructured":"Shin HJ, Baek HM, Ahn JH et al (2012) Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and MRS. NMR Biomed 25:1349\u20131359. https:\/\/doi.org\/10.1002\/nbm.2807","journal-title":"NMR Biomed"},{"key":"11640_CR15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/jmri.24843","volume":"42","author":"S Liu","year":"2015","unstructured":"Liu S, Ren R, Chen Z et al (2015) Diffusion-weighted imaging in assessing pathological response of tumor in breast cancer subtype to neoadjuvant chemotherapy. J Magn Reson Imaging 42:779\u2013787. https:\/\/doi.org\/10.1002\/jmri.24843","journal-title":"J Magn Reson Imaging"},{"key":"11640_CR16","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","volume":"24","author":"A Prat","year":"2015","unstructured":"Prat A, Pineda E, Adamo B et al (2015) Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast 24:S26\u2013S35. https:\/\/doi.org\/10.1016\/j.breast.2015.07.008","journal-title":"Breast"},{"key":"11640_CR17","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1158\/1055-9965.EPI-13-1170","volume":"23","author":"SG Elias","year":"2014","unstructured":"Elias SG, Adams A, Wisner DJ et al (2014) Imaging features of HER2 overexpression in breast cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 23:1464\u20131483. https:\/\/doi.org\/10.1158\/1055-9965.EPI-13-1170","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"11640_CR18","doi-asserted-by":"publisher","first-page":"110372","DOI":"10.1016\/j.ejrad.2022.110372","volume":"154","author":"R Ota","year":"2022","unstructured":"Ota R, Kataoka M, Iima M et al (2022) Evaluation of pathological complete response after neoadjuvant systemic treatment of invasive breast cancer using diffusion-weighted imaging compared with dynamic contrast-enhanced based kinetic analysis. Eur J Radiol 154:110372. https:\/\/doi.org\/10.1016\/j.ejrad.2022.110372","journal-title":"Eur J Radiol"},{"key":"11640_CR19","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1200\/JCO.2010.31.1258","volume":"29","author":"CE Loo","year":"2011","unstructured":"Loo CE, Straver ME, Rodenhuis S et al (2011) Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype. J Clin Oncol 29:660\u2013666. https:\/\/doi.org\/10.1200\/JCO.2010.31.1258","journal-title":"J Clin Oncol"},{"key":"11640_CR20","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1007\/s00330-021-08461-0","volume":"32","author":"J Kim","year":"2022","unstructured":"Kim J, Han BK, Ko EY, Ko ES, Choi JS, Park KW (2022) Prediction of pathologic complete response on MRI in patients with breast cancer receiving neoadjuvant chemotherapy according to molecular subtypes. Eur Radiol 32:4056\u20134066. https:\/\/doi.org\/10.1007\/s00330-021-08461-0","journal-title":"Eur Radiol"},{"key":"11640_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00475-1","volume":"8","author":"LM Janssen","year":"2022","unstructured":"Janssen LM, den Dekker BM, Gilhuijs KGA, van Diest PJ, van der Wall E, Elias SG (2022) MRI to assess response after neoadjuvant chemotherapy in breast cancer subtypes: a systematic review and meta-analysis. NPJ Breast Cancer 8:107. https:\/\/doi.org\/10.1038\/s41523-022-00475-1","journal-title":"NPJ Breast Cancer"},{"key":"11640_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/SLA.0b013e3182686bd9","volume":"257","author":"HG Moon","year":"2013","unstructured":"Moon HG, Han W, Ahn SK et al (2013) Breast cancer molecular phenotype and the use of HER2-targeted agents influence the accuracy of breast MRI after neoadjuvant chemotherapy. Ann Surg 257:133\u2013137. https:\/\/doi.org\/10.1097\/SLA.0b013e3182686bd9","journal-title":"Ann Surg"},{"key":"11640_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1148\/radiol.2019182947","volume":"292","author":"RM Mann","year":"2019","unstructured":"Mann RM, Cho N, Moy L (2019) Breast MRI: state of the art. Radiology 292:520\u2013536. https:\/\/doi.org\/10.1148\/radiol.2019182947","journal-title":"Radiology"},{"key":"11640_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.clbc.2018.05.009","volume":"18","author":"Y Kim","year":"2018","unstructured":"Kim Y, Sim SH, Park B et al (2018) Magnetic resonance imaging (MRI) assessment of residual breast cancer after neoadjuvant chemotherapy: relevance to tumor subtypes and MRI interpretation threshold. Clin Breast Cancer 18:459\u2013467.e451. https:\/\/doi.org\/10.1016\/j.clbc.2018.05.009","journal-title":"Clin Breast Cancer"},{"key":"11640_CR25","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1245\/s10434-011-1912-z","volume":"18","author":"KP McGuire","year":"2011","unstructured":"McGuire KP, Toro-Burguete J, Dang H et al (2011) MRI staging after neoadjuvant chemotherapy for breast cancer: Does tumor biology affect accuracy?. Ann Surg Oncol 18:3149\u20133154. https:\/\/doi.org\/10.1245\/s10434-011-1912-z","journal-title":"Ann Surg Oncol"},{"key":"11640_CR26","doi-asserted-by":"publisher","first-page":"e0138702","DOI":"10.1371\/journal.pone.0138702","volume":"10","author":"O Arponen","year":"2015","unstructured":"Arponen O, Sudah M, Masarwah A et al (2015) Diffusion-weighted imaging in 3.0 tesla breast MRI: diagnostic performance and tumor characterization using small subregions vs. whole tumor regions of interest. PLoS One 10:e0138702. https:\/\/doi.org\/10.1371\/journal.pone.0138702","journal-title":"PLoS One"},{"key":"11640_CR27","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1007\/s00330-019-06510-3","volume":"30","author":"P Baltzer","year":"2020","unstructured":"Baltzer P, Mann RM, Iima M et al (2020) Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group. Eur Radiol 30:1436\u20131450. https:\/\/doi.org\/10.1007\/s00330-019-06510-3","journal-title":"Eur Radiol"},{"key":"11640_CR28","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","volume":"30","author":"G von Minckwitz","year":"2012","unstructured":"von Minckwitz G, Untch M, Blohmer JU et al (2012) Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 30:1796\u20131804. https:\/\/doi.org\/10.1200\/JCO.2011.38.8595","journal-title":"J Clin Oncol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11640-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11640-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11640-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:44:28Z","timestamp":1763639068000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11640-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11640"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11640-y","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Hak Hee Kim.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Seunghee Baek kindly provided statistical advice for this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"There is no overlap in study subjects or cohorts with previous reports.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}